Safety and Efficacy of Artemisinin 500 mg capsule in Treatment of Adult Subjects with COVID-19 : A Prospective, Randomized, Multi-center, Open label, Interventional Study to Evaluate the Safety and Efficacy of Artemisinin 500 mg capsule in Treatment of Adult Subjects with COVID-19

Medienart:

Klinische Studie

Erscheinungsjahr:

2023

Erschienen:

2023

Enthalten in:

WHO International Clinical Trials Registry Platform - (2023) vom: 29. Mai Zur Gesamtaufnahme - year:2023

Sprache:

Englisch

Links:

Volltext [kostenfrei]

Themen:

610
Medical Condition: Corona Virus COVID-19;Corona Virus COVID-19
Recruitment Status: Not yet recruiting
Study Type: Interventional

Anmerkungen:

WHO International Clinical Trials Registry Platform (https://www.who.int/ictrp/en/), First posted: 22-11-2020, Last updated: 2023-06-05

ICTRP ID:

PACTR202012892855610

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

WHO007487711